Opicapone Analysis of Health Economic Costs in Clinical Practice in Parkinson's Disease UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study

被引：0
|
作者：
Lees, A.
Reichmann, H.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
LEVODOPA; ADJUNCT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
505
引用
收藏
页码：S218 / S219
页数：2
相关论文
共 50 条
  • [21] Influence of demographic characteristics on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: findings from the real-world OPTIPARK study
    Mohamed, B.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S223 - S223
  • [22] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: Findings from the real-world OPTIPARK study
    Pavese, Nicola
    Lees, Andrew
    Reichmann, Heinz
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 268 - 269
  • [23] Influence of levodopa daily dose on the effectiveness of opicapone in Parkinson's disease patients with motor fluctuations: Findings from the real-world OPTIPARK study
    Carrolla, Camille
    Lees, Andrew
    Reichmann, Heinz
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 268 - 268
  • [24] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of entacapone: Findings from the real-world OPTIPARK study
    Jost, Wolfgang
    Reichmann, Heinz
    Lees, Andrew
    Marinho, Daniela
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 276 - 276
  • [25] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of entacapone: findings from the real-world OPTIPARK study
    Jost, W.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S214 - S214
  • [26] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: findings from the real-world OPTIPARK study
    Pavese, N.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S228 - S229
  • [27] Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
    Heinz Reichmann
    Andrew Lees
    José-Francisco Rocha
    Diogo Magalhães
    Patrício Soares-da-Silva
    Translational Neurodegeneration, 9
  • [28] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of dopamine agonists: Findings from the real-world OPTIPARK study
    Jost, Wolfgang
    Reichmann, Heinz
    Lees, Andrew
    Marinho, Daniela
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 272 - 272
  • [29] Onset of Drug-Related Adverse Events in Parkinson's Disease Patients with Motor Fluctuations Treated with Opicapone in Clinical Practice: OPTIPARK Post-Hoc Analysis
    Lees, Andrew J.
    Reichmann, Heinz
    Rocha, Jose-Francisco
    Magalhaes, Diogo
    Liang, Grace S.
    Soares-da-Silva, Patricio
    ANNALS OF NEUROLOGY, 2020, 88 : S185 - S185
  • [30] Onset of Drug-Related Adverse Events in Parkinson's Disease Patients with Motor Fluctuations Treated with Opicapone in Clinical Practice: OPTIPARK Post-Hoc Analysis
    Lees, A.
    Reichmann, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S462 - S464
12345